On this episode of Stock Movers:
- GSK raised its profit and sales forecasts for the year, aided by its HIV and immunology medicines, in Emma Walmsley’s last report as CEO.
- Mercedes-Benz Group confirmed its annual outlook and plans to proceed with a €2 billion share buyback after the company’s margin climbed in 3Q.
- Equinor said 3Q earnings slumped as oil prices softened and trading profits declined, its adjusted operating income after tax fell by about a quarter to $1.51 billion, missing the average analyst estimate.
See omnystudio.com/listener for privacy information.
